The role of hypoxia, vascular endothelial injury, and thrombotic inflammation in worsening
COVID-19 symptoms has been generally recognized. Damaged vascular endothelium plays …

Coronavirus Disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and is frequently complicated by thrombosis. In some cases of …

Background: Thrombosis is a characteristic complication in coronavirus disease 2019
(COVID-19). Since coagulopathy has been observed over the entire clinical course …

Background Data on thrombosis and current real-world management strategies for
anticoagulation therapy are scarce but important for understanding current issues and …

Background The coronavirus disease 2019 (COVID-19) causes extensive coagulopathy and
a potential benefit of anticoagulation therapy has been documented for prevention of …

Introduction There has been limited data on the influence of sex on development of
thrombosis in patients with coronavirus disease 2019 (COVID-19). Materials and methods …

Background The influence of obesity on the development of thrombosis and severity of
coronavirus disease 2019 (COVID-19) remains unclear. Method The CLOT-COVID study …

Background Data on prophylactic anticoagulation are important in understanding the current
issues, unmet needs, and optimal management of Japanese COVID-19 patients. Objectives …

Background: Reports of mortality-associated risk factors in patients with the novel
coronavirus disease 2019 (COVID-19) are limited. Methods: We evaluated the clinical …

Patients with coronavirus disease-2019 (COVID-19) have an increased risk of thrombosis
and acute respiratory distress syndrome (ARDS). Thrombosis is often attributed to increases …